Filed: 2/12/2026ACC: 0001193125-26-048719
📋 What this filing means
VERSANT VENTURE MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 7 equity positions with a total reported market value of $151.06M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
7
Positions
$151.06M
Total AUM (reported)
11.53M
Total Shares
Allocation by class
COMMON STOCK$143.26M94.8%
COMMON SHARES$7.80M5.2%
Portfolio Concentration
Top 3$134.77M89.2%
4–10$16.29M10.8%
Top 3 weight
89.2%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 11.53M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
11.53M
shares
% of voting shares100.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other7
Dominant voting typeShared · 100.0% of voting shares
Institutional Holdings7
Rows:
Monte Rosa Therapeutics, Inc.
OTRShares4.38M
TypeSH
Market value$68.72M
45.49%
Sole
0.00
Shared
4.38M
None
0.00
Lenz Therapeutics, Inc.
OTRShares2.66M
TypeSH
Market value$42.51M
28.14%
Sole
0.00
Shared
2.66M
None
0.00
Jade Biosciences, Inc.
OTRShares1.53M
TypeSH
Market value$23.54M
15.59%
Sole
0.00
Shared
1.53M
None
0.00
CRISPR Therapeutics AG
OTRShares148.83K
TypeSH
Market value$7.80M
5.17%
Sole
0.00
Shared
148.83K
None
0.00
Contineum Therapeutics, Inc.
OTRShares542.63K
TypeSH
Market value$6.20M
4.11%
Sole
0.00
Shared
542.63K
None
0.00
Skye Bioscience, Inc.
OTRShares2.01M
TypeSH
Market value$1.51M
1.00%
Sole
0.00
Shared
2.01M
None
0.00
Tempest Therapeutics, Inc.
OTRShares269.77K
TypeSH
Market value$774.2K
0.51%
Sole
0.00
Shared
269.77K
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Monte Rosa Therapeutics, Inc.OTR | Common Stock | 4.38M | SH | $68.72M 45.49% | 0.00 | 4.38M | 0.00 |
Lenz Therapeutics, Inc.OTR | Common Stock | 2.66M | SH | $42.51M 28.14% | 0.00 | 2.66M | 0.00 |
Jade Biosciences, Inc.OTR | Common Stock | 1.53M | SH | $23.54M 15.59% | 0.00 | 1.53M | 0.00 |
CRISPR Therapeutics AGOTR | Common Shares | 148.83K | SH | $7.80M 5.17% | 0.00 | 148.83K | 0.00 |
Contineum Therapeutics, Inc.OTR | Common Stock | 542.63K | SH | $6.20M 4.11% | 0.00 | 542.63K | 0.00 |
Skye Bioscience, Inc.OTR | Common Stock | 2.01M | SH | $1.51M 1.00% | 0.00 | 2.01M | 0.00 |
Tempest Therapeutics, Inc.OTR | Common Stock | 269.77K | SH | $774.2K 0.51% | 0.00 | 269.77K | 0.00 |